L. Charette

Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D₄ receptor antagonist

Thomas R. Jones, Robert Zamboni, Michel Belley et al. · Canadian Journal of Physiology and Pharmacology · 1989 · 271 citations

Medicine, Pharmacology, Biochemical Pharmacology +9

Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D₄receptor antagonist

Thomas R. Jones, Marc Labelle, Michel Belley et al. · Canadian Journal of Physiology and Pharmacology · 1995 · 251 citations

Medicine, Pharmacology, Cellular Pharmacology +10

Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.

Tom R. Jones, L. Charette, María L. García et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 151 citations

Medicine, Pharmacology, Physiology +17

Gastro-oesophageal reflux and childhood asthma: the acid test.

N M Wilson, L. Charette, Anne Thomson et al. · Thorax · 1985 · 71 citations · Full text

Medicine, Internal Medicine, Pediatrics +10

L-649,923, Sodium (β<i>S</i>*, γ<i>R</i>*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)-γ-hydroxy-β-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist

Thomas R. Jones, Robert N. Young, Éric Champion et al. · Canadian Journal of Physiology and Pharmacology · 1986 · 63 citations

Medicine, Medicinal Chemistry, Pharmacology +9